检验医学
檢驗醫學
검험의학
LABORATORY MEDICINE
2014年
11期
1141-1143
,共3页
徐飞%刘雪梅%迟富丽%谈华%常勇%曹波
徐飛%劉雪梅%遲富麗%談華%常勇%曹波
서비%류설매%지부려%담화%상용%조파
嗜麦芽寡养单胞菌%耐药性%抗菌药物
嗜麥芽寡養單胞菌%耐藥性%抗菌藥物
기맥아과양단포균%내약성%항균약물
Stenotrophomonas maltophilia%Drug resistance%Antibiotic
目的:了解嗜麦芽寡养单胞菌的临床分布及对抗菌药物的耐药性。方法采用 VITEK-2 COMPACT全自动微生物鉴定仪及纸片扩散(K-B)法对分离的63株嗜麦芽寡养单胞菌的来源分布、药物敏感性结果进行统计分析。结果63株嗜麦芽寡养单胞菌在临床标本中分布以痰液为主,占87.3%;感染主要发生在新生儿科为17.4%和胸外科17.4%;其次为呼吸科14.3%和重症监护病房(ICU)14.3%;嗜麦芽寡养单胞菌对亚胺培南耐药率为100.0%;而对左氧氟沙星、米诺环素、磺胺甲口恶唑-甲氧苄啶耐药率较低分别为1.6%、3.2%、3.2%。结论应加强对嗜麦芽寡养单胞菌耐药性监测,以指导临床根据药物敏感性试验结果合理选择抗菌药物。
目的:瞭解嗜麥芽寡養單胞菌的臨床分佈及對抗菌藥物的耐藥性。方法採用 VITEK-2 COMPACT全自動微生物鑒定儀及紙片擴散(K-B)法對分離的63株嗜麥芽寡養單胞菌的來源分佈、藥物敏感性結果進行統計分析。結果63株嗜麥芽寡養單胞菌在臨床標本中分佈以痰液為主,佔87.3%;感染主要髮生在新生兒科為17.4%和胸外科17.4%;其次為呼吸科14.3%和重癥鑑護病房(ICU)14.3%;嗜麥芽寡養單胞菌對亞胺培南耐藥率為100.0%;而對左氧氟沙星、米諾環素、磺胺甲口噁唑-甲氧芐啶耐藥率較低分彆為1.6%、3.2%、3.2%。結論應加彊對嗜麥芽寡養單胞菌耐藥性鑑測,以指導臨床根據藥物敏感性試驗結果閤理選擇抗菌藥物。
목적:료해기맥아과양단포균적림상분포급대항균약물적내약성。방법채용 VITEK-2 COMPACT전자동미생물감정의급지편확산(K-B)법대분리적63주기맥아과양단포균적래원분포、약물민감성결과진행통계분석。결과63주기맥아과양단포균재림상표본중분포이담액위주,점87.3%;감염주요발생재신생인과위17.4%화흉외과17.4%;기차위호흡과14.3%화중증감호병방(ICU)14.3%;기맥아과양단포균대아알배남내약솔위100.0%;이대좌양불사성、미낙배소、광알갑구악서-갑양변정내약솔교저분별위1.6%、3.2%、3.2%。결론응가강대기맥아과양단포균내약성감측,이지도림상근거약물민감성시험결과합리선택항균약물。
Objective To investigate the clinical distribution and drug resistance of Stenotrophomonas maltophilia. Methods The clinical distribution and drug resistance analysis for 63 isolates of Stenotrophomonas maltophilia were performed by VITEK-2 COMPACT system and Kirby-Bauer (K-B)method.The results were analyzed statistically. Results The isolation rate was the highest in respiratory specimens .There was a highest isolation rate of 87.3%.The samples were mainly obtained from the wards of Neonatology Department (1 7.4%)and Thoracic Surgery(1 7.4%), followed by Respiratory Department (4.3%) and Intensive Care Unit (ICU ) (1 4.3%).The 63 isolates of Stenotrophomonas maltophilia were highly resistant to imipenem,and the resistance rate was 1 00.0%.The resistance rates to levofloxacin,minocyline and triethoprim-sulfamethoxazole were 1 .6%,3.2% and 3.2%.Conclusions It should enhance drug resistance monitoring of Stenotrophomonas maltophilia.Treatment based on drug susceptibility test should be adapted as soon as possible.